These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31487213)

  • 1. An overview of nanogel-based vaccines.
    Hernández-Adame L; Angulo C; García-Silva I; Palestino G; Rosales-Mendoza S
    Expert Rev Vaccines; 2019 Sep; 18(9):951-968. PubMed ID: 31487213
    [No Abstract]   [Full Text] [Related]  

  • 2. Nanogel-Mediated antigen delivery: Biocompatibility, immunogenicity, and potential for tailored vaccine design across species.
    Laura Soriano Pérez M; Montironi I; Alejandro Funes J; Margineda C; Campra N; Noelia Cariddi L; José Garrido J; Molina M; Alustiza F
    Vaccine; 2024 Jun; 42(17):3721-3732. PubMed ID: 38719694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research progress of self-assembled nanogel and hybrid hydrogel systems based on pullulan derivatives.
    Zhang T; Yang R; Yang S; Guan J; Zhang D; Ma Y; Liu H
    Drug Deliv; 2018 Nov; 25(1):278-292. PubMed ID: 29334800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a nanogel-based nasal vaccine as a novel antigen delivery system.
    Nakahashi-Ouchida R; Yuki Y; Kiyono H
    Expert Rev Vaccines; 2017 Dec; 16(12):1231-1240. PubMed ID: 29053938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current advances in self-assembled nanogel delivery systems for immunotherapy.
    Tahara Y; Akiyoshi K
    Adv Drug Deliv Rev; 2015 Dec; 95():65-76. PubMed ID: 26482187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-sensitive and specific ligand-conjugated chitosan nanogels for efficient drug delivery.
    Xing L; Fan YT; Shen LJ; Yang CX; Liu XY; Ma YN; Qi LY; Cho KH; Cho CS; Jiang HL
    Int J Biol Macromol; 2019 Dec; 141():85-97. PubMed ID: 31473314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein antigen conjugated with cholesteryl amino-pullulan nanogel shows delayed degradation in dendritic cells and augmented immunogenicity.
    Long W; Kunitake S; Sawada SI; Akiyoshi K; Tsubata T
    Vaccine; 2021 Dec; 39(52):7526-7530. PubMed ID: 34852944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cationic pullulan nanogel as a safe and effective nasal vaccine delivery system for respiratory infectious diseases.
    Nakahashi-Ouchida R; Yuki Y; Kiyono H
    Hum Vaccin Immunother; 2018; 14(9):2189-2193. PubMed ID: 29624474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comprehensive Outlook of Synthetic Strategies and Applications of Redox-Responsive Nanogels in Drug Delivery.
    Kumar P; Liu B; Behl G
    Macromol Biosci; 2019 Aug; 19(8):e1900071. PubMed ID: 31298803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smart Stimuli-responsive Alginate Nanogels for Drug Delivery Systems and Cancer Therapy: A Review.
    Garshasbi HR; Naghib SM
    Curr Pharm Des; 2023; 29(44):3546-3562. PubMed ID: 38115614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanogel-based nasal vaccines for infectious and lifestyle-related diseases.
    Azegami T; Yuki Y; Nakahashi R; Itoh H; Kiyono H
    Mol Immunol; 2018 Jun; 98():19-24. PubMed ID: 29096936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancement in nanogel formulations provides controlled drug release.
    Ahmed S; Alhareth K; Mignet N
    Int J Pharm; 2020 Jun; 584():119435. PubMed ID: 32439585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution assessment of cationic pullulan nanogel, a nasal vaccine delivery system, in mice and non-human primates.
    Yuki Y; Harada N; Sawada SI; Uchida Y; Nakahashi-Ouchida R; Mori H; Yamanoue T; Machita T; Kanazawa M; Fukumoto D; Ohba H; Miyazaki T; Akiyoshi K; Fujihashi K; Kiyono H
    Vaccine; 2023 Jul; 41(34):4941-4949. PubMed ID: 37385890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategic Design of Intelligent-Responsive Nanogel Carriers for Cancer Therapy.
    Wang H; Gao L; Fan T; Zhang C; Zhang B; Al-Hartomy OA; Al-Ghamdi A; Wageh S; Qiu M; Zhang H
    ACS Appl Mater Interfaces; 2021 Nov; 13(46):54621-54647. PubMed ID: 34767342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanogel vaccines targeting dendritic cells: contributions of the surface decoration and vaccine cargo on cell targeting and activation.
    Thomann-Harwood LJ; Kaeuper P; Rossi N; Milona P; Herrmann B; McCullough KC
    J Control Release; 2013 Mar; 166(2):95-105. PubMed ID: 23220107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational Design of Nanogels for Overcoming the Biological Barriers in Various Administration Routes.
    Zhao Q; Zhang S; Wu F; Li D; Zhang X; Chen W; Xing B
    Angew Chem Int Ed Engl; 2021 Jun; 60(27):14760-14778. PubMed ID: 31591803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Nanogels as drug carriers - Introduction, chemical aspects, release mechanisms and potential applications".
    Shah S; Rangaraj N; Laxmikeshav K; Sampathi S
    Int J Pharm; 2020 May; 581():119268. PubMed ID: 32240803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligonucleotide based nanogels for cancer therapeutics.
    Hatami H; Rahiman N; Mohammadi M
    Int J Biol Macromol; 2024 May; 267(Pt 2):131401. PubMed ID: 38582467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gold nanoparticles and vaccine development.
    Salazar-González JA; González-Ortega O; Rosales-Mendoza S
    Expert Rev Vaccines; 2015; 14(9):1197-211. PubMed ID: 26152550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic versus anionic core-shell nanogels for transport of cisplatin to lung cancer cells.
    Gonzalez-Urias A; Zapata-Gonzalez I; Licea-Claverie A; Licea-Navarro AF; Bernaldez-Sarabia J; Cervantes-Luevano K
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110365. PubMed ID: 31344612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.